 | | DRUG: Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate | |
Entry |
|
Name |
Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate; Huscode (TN) |
Component |
Dihydrocodeine phosphate [DR: D01481], dl-Methylephedrine hydrochloride [DR: D02109], Chlorpheniramine maleate [DR: D00665]
|
Class |
|
Remark |
Therapeutic category: | 2229 |
|
Efficacy |
Antitussive |
Comment |
Dihydrocodeine phosphate is metabolized by UGT2B7, UGT2B4 with some contribution from CYP3A4 and CYP2D6.
|
Metabolism |
Enzyme: UGT2B7 [HSA: 7364], UGT2B4 [HSA: 7363]; CYP3A4 [HSA: 1576], CYP2D6 [HSA: 1565]
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AB Substituted alkylamines
R06AB54 Chlorphenamine, combinations
D04313 Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate <JP>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
222 Antitussives
2229 Others
D04313 Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
D04313 Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D04313 Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate
DG02924 UGT substrate
DG03189 UGT2B4 substrate
D04313 Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate
DG03190 UGT2B7 substrate
D04313 Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D04313
|
Other DBs |
|
LinkDB |
|
|
» Japanese version » Back
|